Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating, Cuts Target Price to $28
OrthoPediatrics Is Maintained at Hold by Truist Securities
Bears Are Losing Control Over OrthoPediatrics (KIDS), Here's Why It's a 'Buy' Now
Shareholders in OrthoPediatrics (NASDAQ:KIDS) Have Lost 58%, as Stock Drops 7.6% This Past Week
Does OrthoPediatrics (KIDS) Have the Potential to Rally 36.3% as Wall Street Analysts Expect?
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating, Announces Target Price $34
Truist Financial analyst Richard Newitter maintains $OrthoPediatrics(KIDS.US)$ with a hold rating, and sets the target price at $34.According to TipRanks data, the analyst has a success rate of 58.8%
Stifel Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $40
Stifel analyst Rick Wise maintains $OrthoPediatrics(KIDS.US)$ with a buy rating, and maintains the target price at $40.According to TipRanks data, the analyst has a success rate of 58.5% and a total
A Quick Look at Today's Ratings for OrthoPediatrics(KIDS.US), With a Forecast Between $34 to $50
On Sep 13, major Wall Street analysts update their ratings for $OrthoPediatrics(KIDS.US)$, with price targets ranging from $34 to $50.Needham analyst Michael Matson maintains with a buy rating, and
OrthoPediatrics Price Target Maintained With a $42.00/Share by Needham
Buy Rating Reaffirmed for OrthoPediatrics on Robust Growth Strategy and Strong Financials
Express News | OrthoPediatrics Corp : Truist Securities Raises Target Price to $34 From $30
OrthoPediatrics Corp. Announces Launch of Enabling Technologies Division
BTIG Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $44
BTIG analyst Ryan Zimmerman maintains $OrthoPediatrics(KIDS.US)$ with a buy rating, and maintains the target price at $44.According to TipRanks data, the analyst has a success rate of 45.9% and a
Piper Sandler Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Raises Target Price to $44
Piper Sandler analyst Matthew O'Brien maintains $OrthoPediatrics(KIDS.US)$ with a buy rating, and adjusts the target price from $40 to $44.According to TipRanks data, the analyst has a success rate
Piper Sandler Reaffirms Their Buy Rating on OrthoPediatrics (KIDS)
Wall Street Analysts Predict a 31.2% Upside in OrthoPediatrics (KIDS): Here's What You Should Know
Orthopediatrics Insider Sold Shares Worth $293,000, According to a Recent SEC Filing
OrthoPediatrics Corp. to Host Investor Day on September 12, 2024
Needham Reiterates Buy on OrthoPediatrics, Maintains $42 Price Target
OrthoPediatrics Enhances Investor Relations With Strategic Presentations